David M. Blank, Partner

Publications and Presentations

01/05/21 – Blog

Brenda M. Maloney Shafer

The End of a Wild Year for 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement PullbackTo Be Or Not To 340BBrenda M. Maloney Shafer, Richard B. Davis, David M. Blank2020 was a tumultuous year for virtually everyone and everything, and the 340B Program was no exception. As we outlined in previous articles, many drug manufacturers have decided that the Health Resources and Services Administration’s Office of Pharmacy Affairs (“HRSA... Read More

10/06/20 – Newsletter DOJ Focuses on Health Care Fraud Schemes Involving Telemedicine & Health Care Facilities White Collar Crime and Internal Investigations Alert Luke Cass, Hector J. Diaz, David M. Blank

05/08/20 – Newsletter Connolly Revisited: Striking the Right Balance Between Conducting an Effective Internal Investigation and Serving as the Government’s Alter Ego White Collar Crime and Internal Investigations Alert Luke Cass, David M. Blank

03/16/20 – Newsletter The Travel Act in Federal Health Care Fraud Prosecutions White Collar Crime and Internal Investigations Alert Luke Cass, David M. Blank, Hector J. Diaz, Mark W. Bina

12/18/19 – Article "OIG Proposed Revisions to AKS Safe Harbor Rules: Implications for Life Sciences Stakeholders" American Health Lawyers Association (AHLA) David M. Blank

07/17/19 "Enforcement Rx: An Overview of Recent Government Actions Target Fraud, Waste, And Abuse in the Pharmacy Sector" Quarles & Brady Pharmacy Law Symposium

04/23/19 – Newsletter ARPO Strike Force Announces Expansion and First Major Takedown OIG Monitor Alert David M. Blank, Luke Cass

09/07/18 – Article “A Look At OIG's Medicare Exclusion Analysis Under FCA” Law360 David Blank

08/28/18 – Newsletter Can You Hear Me Now? OIG Examines Improper Telehealth Payments OIG Monitor David Blank

08/28/18 – Newsletter OIG by the Numbers - June, 2018 OIG Monitor David Blank

08/28/18 – Newsletter The GAO Provides Congress Inside Look at OIG Integrity Obligations OIG Monitor David Blank

08/28/18 – Newsletter OIG Testimony Focuses on Longstanding 340B Program Vulnerabilities OIG Monitor David Blank

07/18/18 – Newsletter OIG Exercises Discretion, Authorizes Free Caregiver Support Services OIG Monitor David Blank

07/12/18 – Newsletter Pharmacy Chain Takes Center Stage in Latest DOJ-OIG Takedown OIG Monitor David Blank, Cory J. Kopitzke

07/05/18 – Newsletter Minding the Gap: OIG Green Light of Medigap Arrangements with PHOs Continues OIG Monitor David Blank

06/26/18 – Newsletter OIG Greenlights Free Telemedicine Equipment Aimed at HIV Prevention OIG Monitor David Blank

06/01/18 – Newsletter When Waste is NOT “Waste”: OIG Deems Free Ostomy Samples As Low Risk OIG Monitor David Blank

05/15/18 – Newsletter OIG by the Numbers January - March, 2018 OIG Monitor David Blank

05/15/18 – Newsletter Second Acts: Exclusion, Reinstatement, and Revocation Oh My! OIG Monitor David Blank, Christopher Guthrie

05/15/18 – Newsletter Problematic Physical Therapy Billing Remains an OIG Priority OIG Monitor David Blank, Cory Kopitzke

05/15/18 – Newsletter OIG Blesses Arrangement Involving "Far Removed" Excluded Person OIG Monitor David Blank, Elizabeth Gebarski

05/15/18 – Newsletter OIG Data Analytics Nab More Fraudulent Pelvic Floor Therapy Providers OIG Monitor David Blank

05/15/18 – Presentation "False Claims Act Trends Impacting Organizational Compliance" Quarles & Brady Seminar David Blank

05/15/18 – Newsletter OIG Closes the Book on Rescinding Advisory Opinion 06-04 OIG Monitor David Blank, Sam Magnuson

04/01/18 – Article "The Government Crackdown on Absentee Providers" Chicago Medicine David Blank

03/26/18 – Presentation "Fraud and Abuse in the Managed Care Setting" AmeriHealth Caritas David M. Blank

02/07/18 – Newsletter Guidance Dethroned: What the Brand Memorandum Means to Health Care Entities Health Law Alert David M. Blank

01/16/18 – Newsletter The Government Crackdown on the Absentee Provider Continues Health Law Alert David M. Blank